Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study

The aim of our study was to investigate regional glucose metabolism with 18F-FDG positron emission tomography/computed tomography in a population of patients with Alzheimer’s disease (AD) in relation to cerebrospinal (CSF) levels of striatal dopamine transporter (DAT). All patients underwent lumbar...

Full description

Bibliographic Details
Main Authors: Riccardo Camedda, Chiara Giuseppina Bonomi, Martina Gaia Di Donna, Agostino Chiaravalloti
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/1/751
_version_ 1797625562915667968
author Riccardo Camedda
Chiara Giuseppina Bonomi
Martina Gaia Di Donna
Agostino Chiaravalloti
author_facet Riccardo Camedda
Chiara Giuseppina Bonomi
Martina Gaia Di Donna
Agostino Chiaravalloti
author_sort Riccardo Camedda
collection DOAJ
description The aim of our study was to investigate regional glucose metabolism with 18F-FDG positron emission tomography/computed tomography in a population of patients with Alzheimer’s disease (AD) in relation to cerebrospinal (CSF) levels of striatal dopamine transporter (DAT). All patients underwent lumbar puncture and received a biomarker-based diagnosis of AD. Differences in regional brain glucose metabolism were assessed by Statistical Parametric Mapping version 12 with the use of age, gender, and MMSE as covariates in the analysis. A positive correlation between CSF DAT levels and glucose metabolism at the level of two brain areas involved in the pathophysiological process of Alzheimer’s disease, the substantia nigra and the posterior cingulate gyrus, has been highlighted. Results indicate that patients with higher CSF DAT levels have a better metabolic pattern in two key zones, suggesting less advanced disease status in patients with more conserved dopaminergic systems.
first_indexed 2024-03-11T09:58:08Z
format Article
id doaj.art-af0cd58e285a4198a7e814d956cf4e7d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:58:08Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-af0cd58e285a4198a7e814d956cf4e7d2023-11-16T15:37:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-0124175110.3390/ijms24010751Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT StudyRiccardo Camedda0Chiara Giuseppina Bonomi1Martina Gaia Di Donna2Agostino Chiaravalloti3Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, ItalyMemory Clinic, Policlinico Tor Vergata, University of Rome, 00133 Rome, ItalyMemory Clinic, Policlinico Tor Vergata, University of Rome, 00133 Rome, ItalyDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, ItalyThe aim of our study was to investigate regional glucose metabolism with 18F-FDG positron emission tomography/computed tomography in a population of patients with Alzheimer’s disease (AD) in relation to cerebrospinal (CSF) levels of striatal dopamine transporter (DAT). All patients underwent lumbar puncture and received a biomarker-based diagnosis of AD. Differences in regional brain glucose metabolism were assessed by Statistical Parametric Mapping version 12 with the use of age, gender, and MMSE as covariates in the analysis. A positive correlation between CSF DAT levels and glucose metabolism at the level of two brain areas involved in the pathophysiological process of Alzheimer’s disease, the substantia nigra and the posterior cingulate gyrus, has been highlighted. Results indicate that patients with higher CSF DAT levels have a better metabolic pattern in two key zones, suggesting less advanced disease status in patients with more conserved dopaminergic systems.https://www.mdpi.com/1422-0067/24/1/751FDG-PETDATAlzheimer’s diseasedopaminergic impairmentdementia
spellingShingle Riccardo Camedda
Chiara Giuseppina Bonomi
Martina Gaia Di Donna
Agostino Chiaravalloti
Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
International Journal of Molecular Sciences
FDG-PET
DAT
Alzheimer’s disease
dopaminergic impairment
dementia
title Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
title_full Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
title_fullStr Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
title_full_unstemmed Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
title_short Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary <sup>18</sup>F-FDG PET/CT Study
title_sort functional correlates of striatal dopamine transporter cerebrospinal fluid levels in alzheimer s disease a preliminary sup 18 sup f fdg pet ct study
topic FDG-PET
DAT
Alzheimer’s disease
dopaminergic impairment
dementia
url https://www.mdpi.com/1422-0067/24/1/751
work_keys_str_mv AT riccardocamedda functionalcorrelatesofstriataldopaminetransportercerebrospinalfluidlevelsinalzheimersdiseaseapreliminarysup18supffdgpetctstudy
AT chiaragiuseppinabonomi functionalcorrelatesofstriataldopaminetransportercerebrospinalfluidlevelsinalzheimersdiseaseapreliminarysup18supffdgpetctstudy
AT martinagaiadidonna functionalcorrelatesofstriataldopaminetransportercerebrospinalfluidlevelsinalzheimersdiseaseapreliminarysup18supffdgpetctstudy
AT agostinochiaravalloti functionalcorrelatesofstriataldopaminetransportercerebrospinalfluidlevelsinalzheimersdiseaseapreliminarysup18supffdgpetctstudy